Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Vanda Pharmaceuticals Announces Participation at the Citi 12th Annual Biotech Conference

Vanda Pharmaceuticals Inc.
Posted on: 06 Sep 17
Vanda Pharmaceuticals Announces Participation at the Citi 12th Annual Biotech Conference

PR Newswire

WASHINGTON, Sept. 6, 2017

WASHINGTON, Sept. 6, 2017 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that it will participate at the Citi 12th Annual Biotech Conference. Vanda will host meetings at the Citi Biotech Conference in Boston on Thursday, September 7, 2017.

About Vanda Pharmaceuticals Inc.

Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda, please visit www.vandapharma.com.

Company Contact:
Jim Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com

View original content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-the-citi-12th-annual-biotech-conference-300514948.html

SOURCE Vanda Pharmaceuticals Inc.

PR Newswire
www.prnewswire.com

Last updated on: 06/09/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.